O-GlcNAc modification: why so intimately associated with phosphorylation?
Tóm tắt
Post-translational modification of proteins at serine and threonine side chains by β-N-acetylglucosamine (O-GlcNAc) mediated by the enzyme β-N-acetylglucosamine transferase has been emerging as a fundamental regulatory mechanism encompassing a wide range of proteins involved in cell division, metabolism, transcription and cell signaling. Furthermore, an extensive interplay between O-GlcNAc modification and serine/threonine phosphorylation in a variety of proteins has been reported to exist. However, our understanding of the regulatory mechanisms involved in O-GlcNAc modification and its interplay with serine/threonine phosphorylation in proteins is still elusive. Recent success in the mapping of O-GlcNAc modification sites in proteins as a result of technological advancement in mass spectrometry have revealed two important clues which may be inherently connected to the regulation of O-GlcNAc modification and its interplay with phosphorylation in proteins. First, almost all O-GlcNAc modified proteins are known phospho proteins. Second, the prevalence of tyrosine phosphorylation among O-GlcNAc modified proteins is exceptionally higher (~68%) than its normal occurrence (~2%) alone. We hypothesize that phosphorylation may be a requisite for O-GlcNAc modification and tyrosine phosphorylation plays a role in the interplay between O-GlcNAc modification and serine/threonine phosphorylation in proteins. In other words, the interplay between O-GlcNAc modification and phosphorylation is not limited to serine/threonine phosphorylation but also includes tyrosine phosphorylation. Our hypothesis provides an opportunity to understand the underlying mechanism involved in O-GlcNAc modification and its interplay with serine/threonine phosphorylation in proteins. Furthermore, implication of our hypothesis extends to tyrosine kinase signaling.
Tài liệu tham khảo
Hart GW, Housley MP, Slawson C: Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature. 2007, 446: 1017-22. 10.1038/nature05815.
Torres CR, Hart GW: Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J Biol Chem. 1984, 259: 3308-17.
Comer FI, Vosseller K, Wells L, Accavitti MA, Hart GW: Characterization of a Mouse Monoclonal Antibody Specific for O-Linked N-Acetylglucosamine. Analytical Biochemistry. 2001, 293: 169-177. 10.1006/abio.2001.5132.
Chou TY, Hart GW, Dang CV: c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J Biol Chem. 1995, 270: 18961-5. 10.1074/jbc.270.32.18961.
Cheng X, Cole RN, Zaia J, Hart GW: Alternative O-glycosylation/O-phosphorylation of the murine estrogen receptor beta. Biochemistry. 2000, 39: 11609-20. 10.1021/bi000755i.
Kamemura K, Hayes BK, Comer FI, Hart GW: Dynamic interplay between O-glycosylation and O-phosphorylation of nucleo-cytoplasmic proteins: alternative glycosylation/phosphorylation of THR-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens. J Biol Chem. 2002, 277: 19229-35. 10.1074/jbc.M201729200.
Wang Z, Udeshi ND, Slawson C, Compton PD, Sakabe K, Cheung WD, Shabanowitz J, Hunt DF, Hart GW: Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesis. Sci Signal. 2010, 3 (104): ra2-10.1126/scisignal.2000526.
Butkinaree C, Park K, Hart GW: O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress. Biochim Biophys Acta. 2010, 1800: 96-106.
Ande SR, Moulik S, Mishra S: Interaction between O-GlcNAc modification and tyrosine phosphorylation of prohibitin: implication for a novel binary switch. PLoS ONE. 2009, 4 (2): e4586-10.1371/journal.pone.0004586.
Whelan SA, Dias WB, Lakshmanan T, Lane MD, Hart GW: Regulation of insulin receptor 1 (IRS-1)/AKT kinase mediated insulin signaling by O-linked {beta}-N-acetylglucosamine (O-GlcNAc) in 3T3-L1 adipocytes. J Biol Chem. 2010, 285: 5204-11. 10.1074/jbc.M109.077818.
Klein A, Berkaw MN, Buse MG, Ball LE: O-GlcNAc modification of insulin receptor substrate-1 (IRS-1) occurs in close proximity to multiple SH2 domain binding motifs. Mol Cell Proteomics. 2009, 8: 2733-45. 10.1074/mcp.M900207-MCP200.
Hornbeck PV, Chabra I, Kornhauser JM, Skrzypek E, Zhang B: PhosphoSite: A bioinformatics resource dedicated to physiological protein phosphorylation. Proteomics. 2004, 4: 1551-61. 10.1002/pmic.200300772.
Hunter T: Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell. 1995, 80: 235-236. 10.1016/0092-8674(95)90405-0.
Yang X, Ongusaha PP, Miles PD, Havstad JC, Zhang F, So WV, Kudlow JE, Michell RH, Olefsky JM, Field SJ, Evans RM: Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature. 2008, 451: 964-70. 10.1038/nature06668.
Wang Z, Pandey A, Hart GW: Dynamic Interplay between O-Linked N-Acetylglucosaminylation and glycogen synthase kinase-3-dependent phosphorylation. Mol Cell Proteomics. 2007, 6: 1365-79. 10.1074/mcp.M600453-MCP200.
Gu Y, Ande SR, Mishra S: Altered O-GlcNAc modification and phosphorylation of mitochondrial proteins in myoblast cells exposed to high glucose. Arch Biochem Biophys. 2011, 505: 98-104. 10.1016/j.abb.2010.09.024.